Floatz logo

Epirubicin

Advanced/Metastatic Gastroesophageal Adenocarcinoma

Diwakar DavarPhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Advanced/Metastatic Gastroesophageal Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Memorial Sloan Kettering Cancer Center
Phase 3BB
Levoleucovorin
Merck Sharp & Dohme LLC
Phase 3BB
LENVATINIB
Merck Sharp & Dohme LLC
Phase 3B

Same molecule, other indications

Epirubicin is also rated in:

Recurrent Breast CarcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Lung Non-Small Cell Squamous CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Recurrent Mycosis FungoidesDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →